Greenberg Traurig (GT) is a proud sponsor of the 2025 Georgia Life Sciences Summit -- a must-attend event for Georgia’s bioscience and MedTech communities.
The Summit provides a forum for professionals from industry, academia, and government to discuss major trends and issues, including topics related to scientific research, product development, financing, business development, and public policy. It is the one time each year companies and universities can showcase Georgia’s bioscience innovation. On Tuesday, August 26, Wayne Elowe will speak on the panel, "Life Sciences Investing in a New Era: Winners, Losers, and What's Changing", which will bring together leading venture capitalists and corporate strategics to explore the latest trends shaping life sciences investment. From AI-driven drug discovery and precision medicine to cell and gene therapies and digital health, this session will unpack where capital is flowing—and why. Panelists will examine how investor appetite is shifting in response to scientific breakthroughs, regulatory changes, and market demand as well as the influence of macroeconomic factors—such as interest rates, IPO market dynamics, and geopolitical pressures—on deal flow, valuations, and exit strategies.
More information can be found here: https://www.galifesciences.org/georgia-life-sciences-summit